The cadence of kidney growth in ADPKD

被引:2
|
作者
Chapman, Arlene [1 ]
机构
[1] Emory Univ, Sch Med, Dept Med, Div Nephrol, Atlanta, GA 30322 USA
关键词
DISEASE; VOLUME; PROGRESSION; CHILDREN;
D O I
10.1038/nrneph.2009.75
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Autosomal-dominant polycystic kidney disease is characterized by the development and expansion of cysts, which ultimately results in kidney failure. The rate of this expansion can now be quantified within a short period of time, which has implications for assessing the risk of renal failure in affected patients.
引用
收藏
页码:311 / 312
页数:3
相关论文
共 50 条
  • [31] CAN KIDNEY LENGTH PERCENTILES PREDICT ADPKD PROGRESSION?
    Stroescu, Ramona
    Chisavu, Flavia
    Steflea, Ruxandra
    Chisavu, Lazar
    Gafencu, Mihai
    PEDIATRIC NEPHROLOGY, 2023, 38 : S245 - S245
  • [32] POLYCYSTIC KIDNEY DISEASE Kidney volume-a crystal ball for ADPKD prognosis?
    Gall, Emilie Cornec-Le
    Le Meur, Yannick
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (09) : 485 - 486
  • [33] Tolvaptan in ADPKD Patients With Very Low Kidney Function
    Torres, Vicente E.
    Gansevoort, Ron T.
    Perrone, Ronald D.
    Chapman, Arlene B.
    Ouyang, John
    Lee, Jennifer
    Japes, Hina
    Nourbakhsh, Ali
    Wang, Tao
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (08): : 2171 - 2178
  • [34] FACTORS AFFECTING RENAL GROWTH IN CHILDREN (C) WITH AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD)
    GABOW, P
    JOHNSON, A
    STRAIN, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 720 - 720
  • [35] A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
    Phil McEwan
    Hayley Bennett Wilton
    Albert C. M. Ong
    Bjarne Ørskov
    Richard Sandford
    Francesco Scolari
    Maria-Cristina V. Cabrera
    Gerd Walz
    Karl O’Reilly
    Paul Robinson
    BMC Nephrology, 19
  • [36] Ketosis moderates the effect on kidney volume in dietary interventions for ADPKD-more insights on the KETO ADPKD trial
    Cukoski, Sadrija
    Kuehn, Adrian
    Lindemann, Christoph Heinrich
    Arjune, Sita
    Meyer, Franziska
    Schoemig, Thomas
    Grosse-Hokamp, Nils
    Schmidt, Johannes
    Antczak, Philipp
    Weimbs, Thomas
    Grundmann, Franziska
    Mueller, Roman-Ulrich
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [37] The Role of Baseline Total Kidney Volume Growth Rate in Predicting Tolvaptan Efficacy for ADPKD Patients: A Feasibility Study
    Dev, Hreedi
    Hu, Zhongxiu
    Blumenfeld, Jon D.
    Sharbatdaran, Arman
    Kim, Yelynn
    Zhu, Chenglin
    Shimonov, Daniil
    Chevalier, James M.
    Donahue, Stephanie
    Wu, Alan
    Roychoudhury, Arindam
    He, Xinzi
    Prince, Martin R.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (05)
  • [38] Ketosis moderates the effect on kidney volume in dietary interventions for ADPKD-more insights on the KETO ADPKD trial
    Cukoski, Sadrija
    Kuehn, Adrian
    Lindemann, Christoph Heinrich
    Arjune, Sita
    Meyer, Franziska
    Schoemig, Thomas
    Grosse-Hokamp, Nils
    Schmidt, Johannes
    Antczak, Philipp
    Weimbs, Thomas
    Grundmann, Franziska
    Mueller, Roman-Ulrich
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1208 - I1209
  • [39] Rapid head growth in a baby with ADPKD: Answers
    Shute, Rachel
    Jeelani, Owase
    Lee, Lucy
    Brennan, Eileen
    Bockenhauer, Detlef
    Barnicoat, Angela
    Shroff, Rukshana
    PEDIATRIC NEPHROLOGY, 2014, 29 (02) : 219 - 221
  • [40] Rapid head growth in a baby with ADPKD: Answers
    Rachel Shute
    Owase Jeelani
    Lucy Lee
    Eileen Brennan
    Detlef Bockenhauer
    Angela Barnicoat
    Rukshana Shroff
    Pediatric Nephrology, 2014, 29 : 219 - 221